The Centers for Medicare and Medicaid Services is rethinking a policy that limits millions of Americans’ access to one of the most effective resources for diagnosing and determining the course of treatment for Alzheimer’s disease.
Evidence continues to mount that exclusion lists – lists of prescription drugs that payers refuse to cover – have less to do with patients and more to do with profits.
A new treatment is expanding options for the 40 million people living with migraine disease.
Even as the federal investigation of pharmacy benefit managers begins, patients continue to get cheated by the companies’ practices.
More than two in five American adults are obese. Annually, 300,000 people die from the illness and hundreds of thousands more from related conditions.
The behind-the-scenes, yet powerful companies who control patients’ access to drugs may soon have to answer for their tactics.
In a victory for patient protections, a federal appellate court upheld a West Virginia law designed to put guardrails on unscrupulous “bad drug” advertising.
There are more than one hundred types of arthritis, but gout is among the most common and the most painful. Gout is caused by too much uric acid in the blood, a condition called hyperuricemia. In addition to causing excruciating attacks, if left untreated, the excess uric acid builds up into deposits. These tophi can […]
Imagine being told you’ll have to self-inject a medication – without instructions – that has only been FDA approved for provider-administration. Chances are, you may not use it at all, even though it means inviting dangerous symptoms.
The Partnership to Advance Cardiovascular Health brought together patient advocates, health care providers and policy experts to discuss solutions to overcome the hurdles that keep cardiovascular patients from accessing the most appropriate care.